These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Treatment of systemic mycoses. Abernathy RS Medicine (Baltimore); 1973 Sep; 52(5):385-94. PubMed ID: 4725961 [No Abstract] [Full Text] [Related]
6. Successful treatment of a recurrent Aspergillus niger otomycosis with local application of voriconazole. Chappe M; Vrignaud S; de Gentile L; Legrand G; Lagarce F; Le Govic Y J Mycol Med; 2018 Jun; 28(2):396-398. PubMed ID: 29673769 [TBL] [Abstract][Full Text] [Related]
11. [An agranulocytic case with Aspergillus diffuse external otitis cured by amphotericin B topic administration]. Lin YW Kansenshogaku Zasshi; 1998 Aug; 72(8):855-6. PubMed ID: 9780592 [No Abstract] [Full Text] [Related]
12. Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. Denning DW; Stevens DA Rev Infect Dis; 1990; 12(6):1147-201. PubMed ID: 2267490 [TBL] [Abstract][Full Text] [Related]
13. Effects of beta-thujaplicin on anti-Malassezia pachydermatis remedy for canine otitis externa. Nakano Y; Wada M; Tani H; Sasai K; Baba E J Vet Med Sci; 2005 Dec; 67(12):1243-7. PubMed ID: 16397383 [TBL] [Abstract][Full Text] [Related]
14. Eosinophilic pneumonia caused by Aspergillus niger: is oral cleansing with amphotericin B efficacious in preventing relapse of allergic pneumonitis? Ogawa H; Fujimura M; Tofuku Y; Kitagawa M J Asthma; 2009 Feb; 46(1):95-8. PubMed ID: 19191146 [TBL] [Abstract][Full Text] [Related]
15. Recommendations for managing Aspergillus osteomyelitis and joint infections based on a review of the literature. Kirby A; Hassan I; Burnie J J Infect; 2006 Jun; 52(6):405-14. PubMed ID: 16239033 [TBL] [Abstract][Full Text] [Related]
16. Otomycosis in Burma, and its treatment. Than KM; Naing KS; Min M Am J Trop Med Hyg; 1980 Jul; 29(4):620-3. PubMed ID: 6447461 [TBL] [Abstract][Full Text] [Related]
17. [Experimental aspergillosis in mice]. Haller I Dermatologica; 1979; 159(Suppl 1):187-90. PubMed ID: 385383 [TBL] [Abstract][Full Text] [Related]
18. Otic administration of amphotericin B 0.25% in sterile water. Kintzel PE; Trausch DE; Copfer AL Ann Pharmacother; 1994 Mar; 28(3):333-5. PubMed ID: 8193421 [TBL] [Abstract][Full Text] [Related]
19. Liposomal nystatin in patients with invasive aspergillosis refractory to or intolerant of amphotericin B. Offner F; Krcmery V; Boogaerts M; Doyen C; Engelhard D; Ribaud P; Cordonnier C; de Pauw B; Durrant S; Marie JP; Moreau P; Guiot H; Samonis G; Sylvester R; Herbrecht R; Antimicrob Agents Chemother; 2004 Dec; 48(12):4808-12. PubMed ID: 15561860 [TBL] [Abstract][Full Text] [Related]
20. Antifungal susceptibility of Aspergillus species isolated from invasive oral infection in neutropenic patients with hematologic malignancies. Myoken Y; Sugata T; Myoken Y; Kyo T; Fujihara M; Mikami Y Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1999 Feb; 87(2):174-9. PubMed ID: 10052372 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]